Drug Type CAR-T |
Synonyms EU 301, EU301 |
Target |
Action blockers |
Mechanism HLA-DR blockers(HLA-DR antigens blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Leukemia | Preclinical | South Korea | 26 Jan 2025 | |
| Diffuse Large B-Cell Lymphoma | Preclinical | South Korea | 26 Jan 2025 |





